NORTHERN TRUST CORP - INVIVO THERAPEUTICS HLDGS CO ownership

INVIVO THERAPEUTICS HLDGS CO's ticker is and the CUSIP is 46186M506. A total of 21 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of INVIVO THERAPEUTICS HLDGS CO
ValueSharesWeighting
Q1 2022$24,000
-25.0%
70,5360.0%0.00%
Q4 2021$32,000
-34.7%
70,5360.0%0.00%
Q3 2021$49,000
-5.8%
70,5360.0%0.00%
Q2 2021$52,000
-25.7%
70,5360.0%0.00%
Q1 2021$70,000
+337.5%
70,536
+252.7%
0.00%
Q4 2020$16,000
-11.1%
19,998
+56.8%
0.00%
Q3 2020$18,00012,7510.00%
Other shareholders
INVIVO THERAPEUTICS HLDGS CO shareholders Q1 2022
NameSharesValueWeighting ↓
IMS Capital Management 20,146$7,0000.00%
VANGUARD GROUP INC 292,603$101,0000.00%
UBS Group AG 25,171$9,0000.00%
IFP Advisors, Inc 1$1,0000.00%
Sugarloaf Wealth Management, LLC 1$00.00%
OSAIC HOLDINGS, INC. 112$00.00%
BANK OF AMERICA CORP /DE/ 5$00.00%
WELLS FARGO & COMPANY/MN 212$00.00%
NORTHERN TRUST CORP 70,536$24,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of INVIVO THERAPEUTICS HLDGS CO shareholders